Ophthalmology market research reports by DelveInsight

• Ocular Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Ocular Pain - Pipeline Insight, 2024 DelveInsight’s, Ocular Pain - Pipeline Insight, 2024,” report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Ocular Pain pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More

• Ocular Inflammation and Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Ocular Inflammation and Pain - Pipeline Insight, 2024 DelveInsight’s, “Ocular Inflammation and Pain – Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Ocular Inflammation and Pain pipeline landscape. It covers the pipeline drug profiles, inc ... Read More

• Thyroid eye disease - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Thyroid eye disease - Pipeline Insight, 2024 Thyroid eye disease Overview ""Thyroid eye disease Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Thyroid eye disease market. A detailed picture of th ... Read More

• Ocular Neuropathic Pain/Corneal Neuropathic Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Ocular Neuropathic Pain/Corneal Neuropathic Pain - Pipeline Insight, 2024 Ocular Neuropathic Pain/Corneal Neuropathic Pain Overview ""Ocular Neuropathic Pain/Corneal Neuropathic Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenar ... Read More

• Acute optic neuritis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Acute optic neuritis - Pipeline Insight, 2024 DelveInsight’s, “Acute optic neuritis - Pipeline Insight, 2024,” report provides comprehensive insights about 2+ companies and 2+ pipeline drugs in Acute optic neuritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonc ... Read More

• Myopia - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Myopia - Pipeline Insight, 2024 DelveInsight’s, “Myopia - Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Myopia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers th ... Read More

• Inflammation and Pain Post Cataract Surgery - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Inflammation and Pain Post Cataract Surgery - Pipeline Insight, 2024 DelveInsight’s, “Inflammation and Pain Post Cataract Surgery – Pipeline Insight, 2024,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Inflammation and Pain Post Cataract Surgery pipeline landsca ... Read More

• Age-related vision dysfunction - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Age-related vision dysfunction - Pipeline Insight, 2024 Age-related vision dysfunction Overview ""Age-related vision dysfunction Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Age-related vision ... Read More

• Geographic Atrophy (GA)- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Geographic Atrophy (GA)- Pipeline Insight, 2024 DelveInsight’s, “Geographic Atrophy - Pipeline Insight, 2024, report provides comprehensive insights about 23+ companies and 25+ pipeline drugs in Geographic Atrophy pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... Read More

• Glaucoma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Glaucoma - Pipeline Insight, 2024 DelveInsight’s, “Glaucoma Disease- Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Glaucoma Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage prod ... Read More

• Uveitic Glaucoma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Uveitic Glaucoma - Pipeline Insight, 2024 Uveitic Glaucoma Overview ""Uveitic Glaucoma Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Uveitic Glaucoma market. A detailed picture of the Uveitic Gl ... Read More

• Fuchs Endothelial Corneal Dystrophy (FECD) - Epidemiology Forecast - 2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Fuchs Endothelial Corneal Dystrophy (FECD) - Epidemiology Forecast - 2034 Key Highlights DelveInsight’s analyst projects that the Total Diagnosed Prevalent Cases of Fuchs Endothelial Corneal Dystrophy (FECD) in the 7MM were ~18.9 million in 2022 and these cases are going to increase during the forec ... Read More

• Chronic Ocular Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Chronic Ocular Pain - Pipeline Insight, 2024 Chronic Ocular Pain Overview ""Chronic Ocular Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Chronic Ocular Pain market. A detailed picture of th ... Read More

• Fuchs Endothelial Corneal Dystrophy (FECD) - Market Insight, Epidemiology And Market Forecast - 2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Fuchs Endothelial Corneal Dystrophy (FECD) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The prevalent cases of schizophrenia are projected to increase during the forecast period (2023–2034) due to the rising awareness regarding mental illness and improvements in diagnosis ... Read More

• Age Related Macular Degeneration - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Age Related Macular Degeneration - Pipeline Insight, 2024 Age Related Macular Degeneration Overview ""Age Related Macular Degeneration Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Age Related M ... Read More

• Dry Eye Disease - Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Dry Eye Disease - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Restrictive Cardiomyopathy market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of Restrictive Cardiomyopathy in the 7MM is expected to increase, drive ... Read More

• Uveitis - Epidemiology Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Uveitis - Epidemiology Forecast - 2034 DelveInsight’s ‘Uveitis – Epidemiology Forecast – 2034’ report delivers an in-depth understanding of uveitis, historical and forecasted epidemiology, as well as the trends in the United States, EU4 (Germany, France, Italy, and Spain), and the United Kingdom, an ... Read More

• Glaucoma Market Insight, Epidemiology And Market Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Glaucoma Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Corneal Edema market is projected to witness consistent growth throughout the forecast period (2023–2034). The market size of Corneal Edema in the US is expected to increase, driven by the launch of emerging therapie ... Read More

• Glaucoma - Epidemiology Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Glaucoma - Epidemiology Forecast - 2034 Key Highlights DelveInsight's analysts project that in the 7MM, around 42% of the total prevalent cases of Glaucoma are diagnosed, owing to factors such as aging populations and enhanced diagnostic techniques facilitating early detection. Approximately 7 milli ... Read More

• Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2024 DelveInsight’s, “Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 80+ pipeline drugs in Dry Age-related Macular Degeneration (Dry-AMD) pipeline ... Read More

• Myopia - Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Myopia - Pipeline Insight, 2024 DelveInsight’s, “Myopia - Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Myopia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers th ... Read More

• Retinal Vein Occlusion - Market Insight, Epidemiology And Market Forecast - 2034

  Jan 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Retinal Vein Occlusion - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The prevalence of retinal vein occlusion has been increasing due to the increase in the geriatric population and the surge in awareness about eye disorders. With the growing geriatric population, the dise ... Read More

• OCS-01 Emerging Drug Insight and Market Forecast − 2032

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 3,250

  OCS-01 Emerging Drug Insight and Market Forecast − 2032 “OCS-01 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about OCS-01 for acute ocular pain (AOP) in the eight major markets. A detailed picture of the OCS-01 for acute ocular pain in the 8MM, i.e., the U ... Read More

• Netarsudil Emerging Drug Insight and Market Forecast − 2032

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 3,250

  Netarsudil Emerging Drug Insight and Market Forecast − 2032 “Netarsudil Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about netarsudil for Fuchs Endothelial Corneal Dystrophy (FECD) in the seven major markets. A detailed picture of the netarsudil for FECD i ... Read More

• Night Vision Disturbances - Market Insight, Epidemiology And Market Forecast - 2032

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 7,500

  Night Vision Disturbances - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights The Night Vision Disturbance (NVD) market is projected to witness consistent growth throughout the forecast period (2023–2032). The market size of Night Vision Disturbance in the 7MM is expected to inc ... Read More

< prev 1 2 3 4 5 6 7 next >